Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Human Organs-on-Chips market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Human Organs-on-Chips market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
Liver-on-a-chip
Kidney-on-a-chip
Intestine-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Other Organs
Segmented by End User/Segment
Pharmaceutical & Biotechnology
Academic & Research Institutes
Cosmetics Industry
Other End Users
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
TissUse GmbH
Tara Biosystems
Nortis Bio
Mimetas
Micronit
Kirkstall
Hesperos
Emulate
Else Kooi Lab
Draper Laboratory
CN Bio Innovations
Cherry Biotech
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Human Organs-on-Chips Market Status and Forecast (2016-2027) 1.3.2 Global Human Organs-on-Chips Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Human Organs-on-Chips Supply by Company 2.1 Global Human Organs-on-Chips Sales Volume by Company 2.2 Global Human Organs-on-Chips Sales Value by Company 2.3 Global Human Organs-on-Chips Price by Company 2.4 Human Organs-on-Chips Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Human Organs-on-Chips Market Status by Category 3.1 Human Organs-on-Chips Category Introduction 3.1.1 Liver-on-a-chip 3.1.2 Kidney-on-a-chip 3.1.3 Intestine-on-a-chip 3.1.4 Lung-on-a-chip 3.1.5 Heart-on-a-chip 3.1.6 Other Organs 3.2 Global Human Organs-on-Chips Market by Category 3.2.1 Global Human Organs-on-Chips Sales Volume by Category (2016-2021) 3.2.2 Global Human Organs-on-Chips Sales Value by Category (2016-2021) 3.2.3 Global Human Organs-on-Chips Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Human Organs-on-Chips Market Status by End User/Segment 4.1 Human Organs-on-Chips Segment by End User/Segment 4.1.1 Pharmaceutical & Biotechnology 4.1.2 Academic & Research Institutes 4.1.3 Cosmetics Industry 4.1.4 Other End Users 4.2 Global Human Organs-on-Chips Market by End User/Segment 4.2.1 Global Human Organs-on-Chips Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Human Organs-on-Chips Sales Value by End User/Segment (2016-2021) 4.2.3 Global Human Organs-on-Chips Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Human Organs-on-Chips Market Status by Region 5.1 Global Human Organs-on-Chips Market by Region 5.1.1 Global Human Organs-on-Chips Sales Volume by Region 5.1.2 Global Human Organs-on-Chips Sales Value by Region 5.2 North America Human Organs-on-Chips Market Status 5.3 Europe Human Organs-on-Chips Market Status 5.4 Asia Pacific Human Organs-on-Chips Market Status 5.5 Central & South America Human Organs-on-Chips Market Status 5.6 Middle East & Africa Human Organs-on-Chips Market Status6 North America Human Organs-on-Chips Market Status 6.1 North America Human Organs-on-Chips Market by Country 6.1.1 North America Human Organs-on-Chips Sales Volume by Country (2016-2021) 6.1.2 North America Human Organs-on-Chips Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Human Organs-on-Chips Market Status 7.1 Europe Human Organs-on-Chips Market by Country 7.1.1 Europe Human Organs-on-Chips Sales Volume by Country (2016-2021) 7.1.2 Europe Human Organs-on-Chips Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Human Organs-on-Chips Market Status 8.1 Asia Pacific Human Organs-on-Chips Market by Country 8.1.1 Asia Pacific Human Organs-on-Chips Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Human Organs-on-Chips Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Human Organs-on-Chips Market Status 9.1 Central & South America Human Organs-on-Chips Market by Country 9.1.1 Central & South America Human Organs-on-Chips Sales Volume by Country (2016-2021) 9.1.2 Central & South America Human Organs-on-Chips Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Human Organs-on-Chips Market Status 10.1 Middle East & Africa Human Organs-on-Chips Market by Country 10.1.1 Middle East & Africa Human Organs-on-Chips Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Human Organs-on-Chips Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Human Organs-on-Chips Manufacturing Cost Analysis 11.5 Human Organs-on-Chips Sales Channel and Distributors Analysis 11.5.1 Human Organs-on-Chips Sales Channel 11.5.2 Human Organs-on-Chips Distributors 11.6 Human Organs-on-Chips Downstream Major Buyers12 Global Human Organs-on-Chips Market Forecast by Category and by End User/Segment 12.1 Global Human Organs-on-Chips Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Human Organs-on-Chips Forecast by Category 12.2.1 Global Human Organs-on-Chips Sales Volume Forecast by Category 12.2.2 Global Human Organs-on-Chips Sales Value Forecast by Category 12.2.3 Global Human Organs-on-Chips Price Forecast by Category 12.3 Global Human Organs-on-Chips Forecast by End User/Segment 12.3.1 Global Human Organs-on-Chips Sales Volume Forecast by End User/Segment 12.3.2 Global Human Organs-on-Chips Sales Value Forecast by End User/Segment 12.3.3 Global Human Organs-on-Chips Price Forecast by End User/Segment13 Global Human Organs-on-Chips Market Forecast by Region/Country 13.1 Global Human Organs-on-Chips Market Forecast by Region (2022-2027) 13.1.1 Global Human Organs-on-Chips Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Human Organs-on-Chips Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 TissUse GmbH 14.1.1 Company Information 14.1.2 Human Organs-on-Chips Product Introduction 14.1.3 TissUse GmbH Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Tara Biosystems 14.2.1 Company Information 14.2.2 Human Organs-on-Chips Product Introduction 14.2.3 Tara Biosystems Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Nortis Bio 14.3.1 Company Information 14.3.2 Human Organs-on-Chips Product Introduction 14.3.3 Nortis Bio Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Mimetas 14.4.1 Company Information 14.4.2 Human Organs-on-Chips Product Introduction 14.4.3 Mimetas Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Micronit 14.5.1 Company Information 14.5.2 Human Organs-on-Chips Product Introduction 14.5.3 Micronit Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Kirkstall 14.6.1 Company Information 14.6.2 Human Organs-on-Chips Product Introduction 14.6.3 Kirkstall Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Hesperos 14.7.1 Company Information 14.7.2 Human Organs-on-Chips Product Introduction 14.7.3 Hesperos Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Emulate 14.8.1 Company Information 14.8.2 Human Organs-on-Chips Product Introduction 14.8.3 Emulate Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Else Kooi Lab 14.9.1 Company Information 14.9.2 Human Organs-on-Chips Product Introduction 14.9.3 Else Kooi Lab Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Draper Laboratory 14.10.1 Company Information 14.10.2 Human Organs-on-Chips Product Introduction 14.10.3 Draper Laboratory Human Organs-on-Chips Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 CN Bio Innovations 14.12 Cherry Biotech15 Conclusion16 Methodology